• Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis

  T. Thiele, T. Alt-Mayer, A. Greinacher and J. Bux - 19/07/2016

• Les produits sanguins thérapeutiques : des médicaments ou des produits de santé à part ?

  O. Garraud et J.-D. Tissot - 14/07/2016

• Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy

  Z. Solh, U. Athale, D. M. Arnold, R. J. Cook, R. Foley and N. M. Heddle - 27/05/2016

• Transfusion of recently donated (fresh) red blood cells (RBCs) does not improve survival in comparison with current practice, while safety of the oldest stored units is yet to be established: a meta-analysis

  K. E. Remy, J. Sun, D. Wang, J. Welsh, S. B. Solomon, H. G. Klein, C. Natanson and I. Cortés-Puch - 05/02/2016

• Reducing the age of transfused red blood cells in hospitals: ordering and allocation policies

  V. Sarhangian, H. Abouee-Mehrizi, O. Baron, O. Berman, N. M. Heddle and R. Barty - 05/02/2016

• Nouveaux risques viraux en transfusion sanguine à l'horizon 2016

  B. Pozzetto, O. Garraud - 16/01/2016

• Influence of early irradiation on in vitro red blood cell (RBC) storage variables of leucoreduced RBCs in additive solution SAG-M

  B. Hauck-Dlimi, T. Braun, R. Eckstein, J. Strobel and R. Zimmermann - 28/12/2015

• The contribution of von Willebrand factor-GPIba interactions to persistent aggregate formation in apheresis platelet concentrates

  H. B. Feys, B. Van Aelst, R. Devloo, P. Vandekerckhove and V. Compernolle - 08/12/2015

• ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion

  B. J. Zaffuto, G. W. Conley, G. C. Connolly, K. F. Henrichs, C. W. Francis, J. M. Heal, N. Blumberg - 03/11/2015